<DOC>
	<DOC>NCT01107067</DOC>
	<brief_summary>The purpose of this study is investigating the effect of testosterone treatment on paraoxonase level in male patients with hypogonadotrophic hypogonadism</brief_summary>
	<brief_title>Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Volunteers patients with hypogonadism Coronary heart disease Other pituitary/hypothalamic disorders or other nonhypogonadism diseases None was receiving vitamins, lipidlowering drugs, or other medications known to interfere with PON1 activity, lipid profile, or gonadal function</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>paraoxonase</keyword>
	<keyword>Hipogonadism</keyword>
</DOC>